Skip to main content
. 2017 Apr 4;8(20):33586–33600. doi: 10.18632/oncotarget.16829

Table 3. Association of NOX4 expression with the clinicopathological characteristics of CRC.

NOX4 expression
clinicopathological feature Category Total (%) Low expression (n = 36, 43.9%) High expression (n = 46, 56.1%) P value
Sex Male 47 (57.3) 22 (46.8) 25 (53.2)
Female 35 (42.7) 14 (40.0) 21 (60.0) 0.539
Age(years) < 65 35 (42.7) 17 (48.6) 18 (51.4)
≥ 65 47 (57.3) 19 (40.4) 28 (59.6) 0.462
Tumor size < 5 cm 35 (42.7) 17 (48.6) 18 (51.4)
≥ 5 cm 47 (57.3) 19 (40.4) 28 (59.6) 0.462
Tumor location Right hemicolon 44 (53.7) 17 (38.6) 27 (61.4)
Left hemicolon 38 (46.3) 19 (50.0) 19 (50.0) 0.301
T classification T1 1 (1.2) 0 (0.0) 1 (100.0)
T2 4 (4.9) 4 (100.0) 0 (0.0)
T3 55 (67.1) 28 (50.9) 27 (49.1)
T4 22 (26.8) 4 (18.2) 18(81.8) 0.005
Lymph node metastasis Absent 41 (50.0) 23 (56.1) 18 (43.9)
Present 41 (50.0) 13 (31.7) 28 (68.3) 0.026
Distant metastasis Absent 73 (89.0) 36 (49.3) 37 (50.7)
Present 9 (11.0) 0 (0.0) 9 (100.0) 0.014
Histological differentiation Well/moderate 60 (73.2) 25 (41.7) 35 (58.3)
poor 22 (26.8) 11 (50.0) 11 (50.0) 0.500

Values in parentheses indicate percentage values. Bold values indicate statistical significance, P < 0.05.